Skip to content

IR Contact

Seres' news, events and other information can be found throughout the pages below.

IR Contact

Carlo Tanzi, Ph.D.

Seres Therapeutics, Inc.
Head of Investor Relations and Corporate Communications
Phone: 617-203-3467
E-mail: ctanzi@serestherapeutics.com